Everence Capital Management’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,734
Closed -$440K 890
2025
Q4
$440K Hold
1,734
0.03% 438
2025
Q3
$429K Buy
1,734
+374
+28% +$89.5K 0.03% 448
2025
Q2
$327K Sell
1,360
-1,310
-49% -$305K 0.02% 548
2025
Q1
$605K Hold
2,670
0.04% 315
2024
Q4
$549K Sell
2,670
-480
-15% -$105K 0.04% 342
2024
Q3
$764K Hold
3,150
0.05% 297
2024
Q2
$644 Hold
3,150
0.04% 318
2024
Q1
$708 Hold
3,150
0.05% 305
2023
Q4
$693K Hold
3,150
0.05% 306
2023
Q3
$691 Buy
+3,150
New +$713K 0.05% 291
2020
Q4
Sell
-2,144
Closed -$378K 735
2020
Q3
$378K Hold
2,144
0.04% 384
2020
Q2
$356K Hold
2,144
0.04% 402
2020
Q1
$300K Hold
2,144
0.04% 376
2019
Q4
$327K Buy
+2,144
New +$314K 0.05% 452

Other funds holding STE

Everence Capital Management's STE Position: Q1 2026 in Review

Everence Capital Management sold out of Steris (STE) in Q1 2026, closing a stake of 1,734 shares — an estimated $440K sold.

Everence Capital Management first reported a position in STE in Q4 2019 and held it in 14 quarters. The position peaked at $764K in Q3 2024. 838 funds tracked by Wall St. Rank hold STE as of Q1 2026.

  • Everence Capital Management reported no remaining Steris position as of Q1 2026 after selling out during the quarter.
  • Everence Capital Management sold 1,734 Steris shares in Q1 2026, an estimated $440K.
  • Everence Capital Management first reported a position in Steris in Q4 2019 and held it in 14 quarters.
  • Everence Capital Management's Steris position peaked at $764K in Q3 2024.
  • 838 funds tracked by Wall St. Rank held Steris as of Q1 2026.

Based on Everence Capital Management's 13F filing for Q1 2026, filed 28 Apr 2026.